1. Home
  2. AGX vs HAE Comparison

AGX vs HAE Comparison

Compare AGX & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$315.82

Market Cap

3.9B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$79.98

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
HAE
Founded
1961
1971
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
3.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
AGX
HAE
Price
$315.82
$79.98
Analyst Decision
Buy
Buy
Analyst Count
4
9
Target Price
$321.00
$84.38
AVG Volume (30 Days)
451.3K
854.6K
Earning Date
12-04-2025
11-06-2025
Dividend Yield
0.63%
N/A
EPS Growth
76.74
42.54
EPS
8.49
3.44
Revenue
$915,030,000.00
$1,327,850,000.00
Revenue This Year
$11.43
N/A
Revenue Next Year
$18.27
$6.01
P/E Ratio
$37.66
$24.30
Revenue Growth
13.49
N/A
52 Week Low
$101.02
$47.32
52 Week High
$399.30
$87.32

Technical Indicators

Market Signals
Indicator
AGX
HAE
Relative Strength Index (RSI) 44.38 60.16
Support Level $307.64 $82.30
Resistance Level $341.00 $87.32
Average True Range (ATR) 19.84 2.21
MACD -6.82 -0.91
Stochastic Oscillator 33.89 19.56

Price Performance

Historical Comparison
AGX
HAE

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: